{"id":"https://openalex.org/W4409377828","doi":"https://doi.org/10.1080/10543406.2025.2489290","title":"The role of regulatory flexibility in the review and approval process of rare disease drug development","display_name":"The role of regulatory flexibility in the review and approval process of rare disease drug development","publication_year":2025,"publication_date":"2025-04-11","ids":{"openalex":"https://openalex.org/W4409377828","doi":"https://doi.org/10.1080/10543406.2025.2489290","pmid":"https://pubmed.ncbi.nlm.nih.gov/40219617"},"language":"en","primary_location":{"id":"doi:10.1080/10543406.2025.2489290","doi":"https://doi.org/10.1080/10543406.2025.2489290","is_oa":false,"landing_page_url":"https://doi.org/10.1080/10543406.2025.2489290","pdf_url":null,"source":{"id":"https://openalex.org/S56946555","display_name":"Journal of Biopharmaceutical Statistics","issn_l":"1054-3406","issn":["1054-3406","1520-5711"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-c","cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Biopharmaceutical Statistics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052915681","display_name":"Shein\u2010Chung Chow","orcid":"https://orcid.org/0000-0001-9560-2757","observed_orcids":["https://orcid.org/0000-0001-9560-2757"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Shein-Chung Chow","raw_affiliation_strings":["Duke University School of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University School of Medicine","institution_ids":["https://openalex.org/I170897317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008194697","display_name":"Anne Pariser","orcid":"https://orcid.org/0000-0002-9421-0126","observed_orcids":["https://orcid.org/0000-0002-9421-0126"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anne Pariser","raw_affiliation_strings":["International Rare Diseases Research Consortium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"International Rare Diseases Research Consortium","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109847852","display_name":"Steven K. Galson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4401726965","display_name":"Boston Consulting Group (United States)","ror":"https://ror.org/01526xe10","country_code":null,"type":"company","lineage":["https://openalex.org/I4401726965"]}],"countries":[],"is_corresponding":false,"raw_author_name":"Steven Galson","raw_affiliation_strings":["Boston Consulting Group"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boston Consulting Group","institution_ids":["https://openalex.org/I4401726965"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5052915681"],"corresponding_institution_ids":["https://openalex.org/I170897317"],"apc_list":null,"apc_paid":null,"fwci":1.7427,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.82993454,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":96,"max":97},"biblio":{"volume":"35","issue":"6","first_page":"1020","last_page":"1031"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.8755000233650208,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.8755000233650208,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T13417","display_name":"Biomedical Ethics and Regulation","score":0.05739999935030937,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.04179999977350235,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/regulatory-flexibility","display_name":"regulatory flexibility","score":1.0},{"id":"https://openalex.org/keywords/rare-disease-drugs","display_name":"rare disease drugs","score":0.8370000123977661},{"id":"https://openalex.org/keywords/drug-approval","display_name":"drug approval","score":0.5950000286102295},{"id":"https://openalex.org/keywords/clinical-trial-design","display_name":"clinical trial design","score":0.4569999873638153},{"id":"https://openalex.org/keywords/statistical-considerations","display_name":"statistical considerations","score":0.4819999933242798},{"id":"https://openalex.org/keywords/regulatory-science","display_name":"regulatory science","score":0.35100001096725464}],"concepts":[{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.6996411085128784},{"id":"https://openalex.org/C2780598303","wikidata":"https://www.wikidata.org/wiki/Q65921492","display_name":"Flexibility (engineering)","level":2,"score":0.6754644513130188},{"id":"https://openalex.org/C2992293740","wikidata":"https://www.wikidata.org/wiki/Q4781752","display_name":"Drug approval","level":3,"score":0.582958996295929},{"id":"https://openalex.org/C98045186","wikidata":"https://www.wikidata.org/wiki/Q205663","display_name":"Process (computing)","level":2,"score":0.5350640416145325},{"id":"https://openalex.org/C2778917124","wikidata":"https://www.wikidata.org/wiki/Q7309705","display_name":"Regulatory science","level":2,"score":0.4762941896915436},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.41909295320510864},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4126071333885193},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.4094827473163605},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.3956761062145233},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.3731929659843445},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.3696521520614624},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3414624333381653},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.29085320234298706},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.18489396572113037},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1638185679912567},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1578163206577301},{"id":"https://openalex.org/C105795698","wikidata":"https://www.wikidata.org/wiki/Q12483","display_name":"Statistics","level":1,"score":0.12409737706184387},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.09636011719703674},{"id":"https://openalex.org/C111919701","wikidata":"https://www.wikidata.org/wiki/Q9135","display_name":"Operating system","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000076722","descriptor_name":"Drug Development","qualifier_ui":"Q000331","qualifier_name":"legislation & jurisprudence","is_major_topic":true},{"descriptor_ui":"D000076722","descriptor_name":"Drug Development","qualifier_ui":"Q000331","qualifier_name":"legislation & jurisprudence","is_major_topic":true},{"descriptor_ui":"D000076722","descriptor_name":"Drug Development","qualifier_ui":"Q000331","qualifier_name":"legislation & jurisprudence","is_major_topic":true},{"descriptor_ui":"D000076722","descriptor_name":"Drug Development","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D000076722","descriptor_name":"Drug Development","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D000076722","descriptor_name":"Drug Development","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D000076722","descriptor_name":"Drug Development","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D000076722","descriptor_name":"Drug Development","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D000076722","descriptor_name":"Drug Development","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":"Q000331","qualifier_name":"legislation & jurisprudence","is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":"Q000331","qualifier_name":"legislation & jurisprudence","is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":"Q000331","qualifier_name":"legislation & jurisprudence","is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009965","descriptor_name":"Orphan Drug Production","qualifier_ui":"Q000331","qualifier_name":"legislation & jurisprudence","is_major_topic":true},{"descriptor_ui":"D009965","descriptor_name":"Orphan Drug Production","qualifier_ui":"Q000331","qualifier_name":"legislation & jurisprudence","is_major_topic":true},{"descriptor_ui":"D009965","descriptor_name":"Orphan Drug Production","qualifier_ui":"Q000331","qualifier_name":"legislation & jurisprudence","is_major_topic":true},{"descriptor_ui":"D009965","descriptor_name":"Orphan Drug Production","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D009965","descriptor_name":"Orphan Drug Production","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D009965","descriptor_name":"Orphan Drug Production","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014486","descriptor_name":"United States Food and Drug Administration","qualifier_ui":"Q000331","qualifier_name":"legislation & jurisprudence","is_major_topic":false},{"descriptor_ui":"D014486","descriptor_name":"United States Food and Drug Administration","qualifier_ui":"Q000331","qualifier_name":"legislation & jurisprudence","is_major_topic":false},{"descriptor_ui":"D014486","descriptor_name":"United States Food and Drug Administration","qualifier_ui":"Q000331","qualifier_name":"legislation & jurisprudence","is_major_topic":false},{"descriptor_ui":"D017277","descriptor_name":"Drug Approval","qualifier_ui":"Q000331","qualifier_name":"legislation & jurisprudence","is_major_topic":true},{"descriptor_ui":"D017277","descriptor_name":"Drug Approval","qualifier_ui":"Q000331","qualifier_name":"legislation & jurisprudence","is_major_topic":true},{"descriptor_ui":"D017277","descriptor_name":"Drug Approval","qualifier_ui":"Q000331","qualifier_name":"legislation & jurisprudence","is_major_topic":true},{"descriptor_ui":"D017277","descriptor_name":"Drug Approval","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D017277","descriptor_name":"Drug Approval","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D017277","descriptor_name":"Drug Approval","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D035583","descriptor_name":"Rare Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D035583","descriptor_name":"Rare Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D035583","descriptor_name":"Rare Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1080/10543406.2025.2489290","doi":"https://doi.org/10.1080/10543406.2025.2489290","is_oa":false,"landing_page_url":"https://doi.org/10.1080/10543406.2025.2489290","pdf_url":null,"source":{"id":"https://openalex.org/S56946555","display_name":"Journal of Biopharmaceutical Statistics","issn_l":"1054-3406","issn":["1054-3406","1520-5711"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-c","cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Biopharmaceutical Statistics","raw_type":"journal-article"},{"id":"pmid:40219617","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/40219617","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of biopharmaceutical statistics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.5683000087738037}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.6700000166893005}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":17,"referenced_works":["https://openalex.org/W1989028508","https://openalex.org/W2000045315","https://openalex.org/W2109056439","https://openalex.org/W2129858452","https://openalex.org/W2149965232","https://openalex.org/W2284735655","https://openalex.org/W2493712194","https://openalex.org/W2740802165","https://openalex.org/W2900300149","https://openalex.org/W2970221106","https://openalex.org/W2970715709","https://openalex.org/W2971193366","https://openalex.org/W3047068212","https://openalex.org/W3137814255","https://openalex.org/W4392015050","https://openalex.org/W4408111014","https://openalex.org/W4409377938"],"related_works":["https://openalex.org/W2945724922","https://openalex.org/W2338367129","https://openalex.org/W1585256759","https://openalex.org/W1502809559","https://openalex.org/W2999793242","https://openalex.org/W3211798705","https://openalex.org/W2029342376","https://openalex.org/W4245533983","https://openalex.org/W2589716039","https://openalex.org/W2462743774"],"abstract_inverted_index":{"The":[0],"role":[1],"of":[2,11,25,29,47,69,73,99,125,128,144,186,194,197],"regulatory":[3,39,52,109,145,174,187],"flexibility":[4,40,84,110,146,175,188],"in":[5,64,91,147,192,202],"the":[6,26,45,51,56,65,89,119,129,142,184,195,198],"review":[7,66],"and":[8,15,32,60,67,76,97,115,122,151,170,176,200],"approval":[9],"process":[10],"rare":[12,148],"disease":[13,149],"drug":[14,150,160,203],"biologics":[16],"development":[17,204],"was":[18],"recently":[19],"studied":[20],"by":[21,50],"a":[22,70,100],"Consensus":[23],"Committee":[24],"National":[27],"Academy":[28],"Sciences,":[30],"Engineering":[31],"Medicine":[33],"(NASEM":[34],"2024).":[35],"In":[36,165],"this":[37],"article,":[38],"is":[41,85],"referred":[42],"to":[43,87,137,159],"as":[44,55],"exercise":[46],"scientific":[48,107,123],"judgement":[49],"agencies":[53],"such":[54],"United":[57],"States":[58],"Food":[59],"Drug":[61],"Administration":[62],"(FDA),":[63],"oversight":[68],"wide":[71],"range":[72],"products,":[74],"diseases":[75],"circumstances":[77],"(see":[78],"e.g.":[79],"21CFR":[80],"Subpart":[81],"E).":[82],"This":[83,134],"intended":[86],"assist":[88],"sponsors":[90],"obtaining":[92],"substantial":[93],"evidence":[94],"regarding":[95,141,183],"safety":[96,199],"effectiveness":[98],"test":[101,130],"treatment":[102,131],"under":[103,132],"investigation.":[104],"Applying":[105],"general":[106],"principles,":[108],"should":[111],"be":[112,157],"transparent,":[113],"objective,":[114],"applied":[116,158],"without":[117],"undermining":[118],"integrity,":[120],"quality":[121],"validity":[124],"clinical":[126],"investigation":[127],"study.":[133],"article":[135],"attempts":[136],"provide":[138],"an":[139],"overview":[140],"application":[143],"biologic":[152],"development,":[153],"which":[154,172],"could":[155],"also":[156],"products":[161],"for":[162],"normal":[163],"conditions.":[164],"addition,":[166],"some":[167],"innovative":[168],"strategies":[169],"approaches":[171],"reflect":[173],"current":[177,190],"thinking":[178,191],"are":[179,205],"proposed.":[180],"Statistical":[181],"considerations":[182],"implementation":[185],"and/or":[189],"support":[193],"demonstration":[196],"efficacy":[201],"discussed.":[206]},"counts_by_year":[{"year":2026,"cited_by_count":2}],"updated_date":"2026-09-16T18:09:00.828671","created_date":"2025-10-10T00:00:00"}